Welcome to the e-CCO Library!

P257: Evaluation of serum ICAM-1 and VCAM-1 as biomarkers for disease progression in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bar Orr I.*1, Martin de Carpi J.2, Amil Dias J.3, Levine A.4, Nuti F.5, Lionetti P.6, Escher J.7

Created: Wednesday, 20 February 2019, 10:36 AM
P257: Is colorectal screening in IBD fit for purpose?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Saeidinejad, M.(1);Dawson, H.E.(2)*;Newbury, C.M.(2);Searle, H.(2);Gordon, J.N.(2);
Created: Friday, 14 July 2023, 11:05 AM
P257: Monitoring of calprotectin levels in IBD patients with point-of-care test CalproSmart™
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Ulanova*1, E. Moerk1

Created: Friday, 22 February 2019, 9:41 AM
P257: Relationship between ocular vascular changes, malondialdehyde and vascular endothelial growth factor levels in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Sengul Samanci1, S. Poturoglu2, C. Samanci3, A. E. Duman*2, A. Ciftcibasi Ormeci2

Created: Friday, 22 February 2019, 9:49 AM
P257: Surgical and hospital admission in adults newly diagnosed with inflammatory bowel disease (IBD) in the biological era in Spain: Results of the nationwide EpidemIBD study of GETECCU
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Chaparro1,2,3,4*, J.L. Cabriada5, M.J. Casanova1,2,4, D. Ceballos6, M. Esteve4,7, H. Fernández8, M. Barreiro-de Acosta9, V. García-Sánchez10,11, D. Ginard12, F. Gomollón4,13,14, R. Llorente Poyatos15, P. Nos4,16, S. Riestra17, M. Rivero18, P. Robledo19, C. Rodríguez Gutiérrez20, B. Sicilia21, E. Torrella22, E. García Esquinas23,24,25, J.P. Gisbert1,2,3,4, on behalf of the EpidemIBD group

Created: Thursday, 21 February 2019, 9:14 AM
P257: The clinical decision support tool has low performance in predicting outcome to ustekinumab in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Alsoud, D.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Verstockt , B.(1,2);Vermeire, S.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P258 Managing an ever-increasing inflammatory bowel disease helpline service
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Scott1, L. Gower1, N. Roads2, W. Lewis3

Created: Thursday, 30 January 2020, 10:12 AM
P258: 3D printed models in fistulising perianal Crohn's as a clinical tool boost education with patients and trainees
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Sahnan1*, S.O. Adegbola1, P.J. Tozer1, A. Gupta2, J. Warusavitarne1, O.D. Faiz1, A.L. Hart3, R.K. Phillips1, P.F. Lung2

Created: Thursday, 21 February 2019, 9:14 AM
P258: Abdominal pain and its relationship with clinical outcomes, biomarker levels, and health-related quality of life in patients with moderate to severe ulcerative colitis: data from U-ACHIEVE, a Phase 2b study of upadacitinib
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Danese*1, E. Louis2, E. V. Loftus Jr3, F. Cataldi4, H. Guay4, W-J. Lee4, S. Ghosh5

Created: Friday, 22 February 2019, 9:41 AM
P258: Disease course and operative risk after diagnosis of ileal penetrating Crohn's disease: a cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bossuyt P.*1,2, Debeuckelaere C.1, Ferrante M.1, De Buck van Overstraeten A.3, Billiet T.1, Vanbeckevoort D.4, Wolthuis A.3, D'Hoore A.3, Van Assche G.1, Vermeire S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P258: Impact of inflammatory bowel diseases on the phenotype and severity of primary sclerosing cholangitis - a systematic review with meta-analysis
Year: 2022
Source: ECCO'22
Authors: Attauabi, M.(1,2,3);Wewer, M.D.(1,3);Bendtsen, F.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3);
Created: Friday, 11 February 2022, 3:52 PM
P258: Prospective follow-up of serologic responses in ulcerative colitis patients with an ileal pouch reveals they are stable over time and do not correlate with the clinical phenotype of the pouch
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Goren*1, L. Yahav2, H. Tulchinsky3, 4, I. Dotan4, 5

Created: Friday, 22 February 2019, 9:49 AM
P258: Rates of admission of acute IBD flares during the COVID-19 pandemic in a tertiary healthcare setting
Year: 2021
Source: ECCO'21 Virtual
Authors: Hazel, K.(1);Glynn, E.(1);Boland, K.(1);O'Toole, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P258: The association between dietary quality and disease severity in Korean young adult patients with Crohn's disease: A pilot study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jeong, E.S.(1)*;Lee, Y.J.(2);Song, E.M.(3);Byeon, J.R.(3);Lee, A.(1);Choe , A.R.(3);Hong, J.T.(1);Park, Y.H.(3);Tae, C.H.(3);Moon, C.M.(1);Jeong, H.K.(1);Shim, K.N.(3);Jung, S.A.(3);Kim, Y.(2);Kim, S.E.(1);
Created: Friday, 14 July 2023, 11:05 AM
P259 Systematic review of prognostic factors affecting the acquisition of transition readiness skills in patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. JOHNSON1, M. Lee1,2, G. Jones3, A. Lobo4

Created: Thursday, 30 January 2020, 10:12 AM
P259: Correlation between the Mayo endoscopic scoring system for Ulcerative Colitis with histological and clinical outcomes
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gibbons, E.(1)*;Afridi, I.(2);Sheehan, T.(2);Smyth, C.(2);Farrell, R.(2);Hall, B.(2);Kelly, O.B.(2);
Created: Friday, 14 July 2023, 11:05 AM
P259: Measures of predicting inflammatory and fibrotic strictures in Crohn’s disease patients using magnetic resonance
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Stack1*, C. O'Brien2, T. Nuzum3, L. Kumar3, P. Maheshwari3, N. Breslin4,5, B. Ryan4,5, A. O'Connor3, I. Murphy6, D. Mc Namara4,5

Created: Thursday, 21 February 2019, 9:14 AM
P259: Metabolic associated Liver Disease and sex as key factors of cardiovascular risk in Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: García Mateo, S.(1,2);Martínez-Domínguez, S.J.(1,2);Ballesta Martínez, S.(3);Espinosa Rueda, J.(3);Tejero Justes, C.(3);Aso Gonzalvo, M.C.(1);Gallego Llera, B.(1);Alfambra Cabreja, E.(1);Baptista, P.M.(2,4);Nocito Colón , M.M.L.(5);Gargallo-Puyuelo , C.J.(1,2);Gomollón, F.(1,6,7);
Created: Friday, 11 February 2022, 3:52 PM
P259: Safety, tolerability and pharmacokinetics of BT051, an oral inhibitor of neutrophil migration and activation in clinical development for Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Murphy, C.(1);Stevens, C.(2);Hershberger, E.(2);Quintas, M.(2);Miller, B.(2);Ghahramani, P.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P259: Systematic assessment of patient self-reported signs, symptoms, and nutrition behaviour
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

V. Pittet*1, M. H. Maillard2, P. Michetti2, Swiss IBD Cohort Study1

Created: Friday, 22 February 2019, 9:41 AM